nodes	percent_of_prediction	percent_of_DWPC	metapath
Trospium—CYP2D6—Fingolimod—multiple sclerosis	0.00912	0.804	CbGbCtD
Trospium—Aclidinium—BCHE—multiple sclerosis	0.00787	1	CrCbGaD
Trospium—CYP2D6—Dexamethasone—multiple sclerosis	0.00222	0.196	CbGbCtD
Trospium—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00215	0.00222	CcSEcCtD
Trospium—Confusional state—Mitoxantrone—multiple sclerosis	0.00215	0.00222	CcSEcCtD
Trospium—Dizziness—Cladribine—multiple sclerosis	0.00214	0.00221	CcSEcCtD
Trospium—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00213	0.0022	CcSEcCtD
Trospium—Oedema—Mitoxantrone—multiple sclerosis	0.00213	0.0022	CcSEcCtD
Trospium—Infection—Mitoxantrone—multiple sclerosis	0.00211	0.00219	CcSEcCtD
Trospium—Eye disorder—Methylprednisolone—multiple sclerosis	0.00211	0.00218	CcSEcCtD
Trospium—Shock—Mitoxantrone—multiple sclerosis	0.00209	0.00216	CcSEcCtD
Trospium—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.00209	0.00216	CcSEcCtD
Trospium—Abdominal pain—Azathioprine—multiple sclerosis	0.00208	0.00215	CcSEcCtD
Trospium—Tachycardia—Mitoxantrone—multiple sclerosis	0.00208	0.00215	CcSEcCtD
Trospium—Skin disorder—Mitoxantrone—multiple sclerosis	0.00207	0.00214	CcSEcCtD
Trospium—Vomiting—Cladribine—multiple sclerosis	0.00206	0.00213	CcSEcCtD
Trospium—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00206	0.00213	CcSEcCtD
Trospium—Angiopathy—Methylprednisolone—multiple sclerosis	0.00205	0.00211	CcSEcCtD
Trospium—Rash—Cladribine—multiple sclerosis	0.00204	0.00211	CcSEcCtD
Trospium—Hallucination—Dexamethasone—multiple sclerosis	0.00204	0.00211	CcSEcCtD
Trospium—Hallucination—Betamethasone—multiple sclerosis	0.00204	0.00211	CcSEcCtD
Trospium—Dermatitis—Cladribine—multiple sclerosis	0.00204	0.00211	CcSEcCtD
Trospium—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.00203	0.0021	CcSEcCtD
Trospium—Weight increased—Prednisone—multiple sclerosis	0.00203	0.0021	CcSEcCtD
Trospium—Headache—Cladribine—multiple sclerosis	0.00203	0.0021	CcSEcCtD
Trospium—Vision blurred—Prednisolone—multiple sclerosis	0.00202	0.00208	CcSEcCtD
Trospium—Visual impairment—Dexamethasone—multiple sclerosis	0.00198	0.00204	CcSEcCtD
Trospium—Visual impairment—Betamethasone—multiple sclerosis	0.00198	0.00204	CcSEcCtD
Trospium—Malnutrition—Methylprednisolone—multiple sclerosis	0.00196	0.00203	CcSEcCtD
Trospium—Angioedema—Prednisolone—multiple sclerosis	0.00195	0.00202	CcSEcCtD
Trospium—Breast disorder—Methotrexate—multiple sclerosis	0.00195	0.00201	CcSEcCtD
Trospium—Dysgeusia—Triamcinolone—multiple sclerosis	0.00193	0.00199	CcSEcCtD
Trospium—Nausea—Cladribine—multiple sclerosis	0.00192	0.00199	CcSEcCtD
Trospium—Syncope—Prednisolone—multiple sclerosis	0.00192	0.00198	CcSEcCtD
Trospium—Eye disorder—Dexamethasone—multiple sclerosis	0.00192	0.00198	CcSEcCtD
Trospium—Eye disorder—Betamethasone—multiple sclerosis	0.00192	0.00198	CcSEcCtD
Trospium—Back pain—Triamcinolone—multiple sclerosis	0.0019	0.00197	CcSEcCtD
Trospium—Somnolence—Mitoxantrone—multiple sclerosis	0.00189	0.00196	CcSEcCtD
Trospium—Loss of consciousness—Prednisolone—multiple sclerosis	0.00188	0.00194	CcSEcCtD
Trospium—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00187	0.00194	CcSEcCtD
Trospium—Angiopathy—Betamethasone—multiple sclerosis	0.00186	0.00192	CcSEcCtD
Trospium—Angiopathy—Dexamethasone—multiple sclerosis	0.00186	0.00192	CcSEcCtD
Trospium—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00185	0.00191	CcSEcCtD
Trospium—Fatigue—Mitoxantrone—multiple sclerosis	0.00183	0.0019	CcSEcCtD
Trospium—Constipation—Mitoxantrone—multiple sclerosis	0.00182	0.00188	CcSEcCtD
Trospium—Angioedema—Triamcinolone—multiple sclerosis	0.0018	0.00186	CcSEcCtD
Trospium—Angioedema—Methylprednisolone—multiple sclerosis	0.00179	0.00185	CcSEcCtD
Trospium—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00179	0.00185	CcSEcCtD
Trospium—Hallucination—Prednisone—multiple sclerosis	0.00178	0.00184	CcSEcCtD
Trospium—Syncope—Triamcinolone—multiple sclerosis	0.00176	0.00182	CcSEcCtD
Trospium—Syncope—Methylprednisolone—multiple sclerosis	0.00176	0.00182	CcSEcCtD
Trospium—Connective tissue disorder—Prednisone—multiple sclerosis	0.00175	0.00181	CcSEcCtD
Trospium—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00175	0.00181	CcSEcCtD
Trospium—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00175	0.0018	CcSEcCtD
Trospium—Oedema—Prednisolone—multiple sclerosis	0.00175	0.0018	CcSEcCtD
Trospium—Dysuria—Methotrexate—multiple sclerosis	0.00174	0.0018	CcSEcCtD
Trospium—Dizziness—Azathioprine—multiple sclerosis	0.00174	0.0018	CcSEcCtD
Trospium—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00174	0.0018	CcSEcCtD
Trospium—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00173	0.00179	CcSEcCtD
Trospium—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00173	0.00178	CcSEcCtD
Trospium—Shock—Prednisolone—multiple sclerosis	0.00172	0.00178	CcSEcCtD
Trospium—Tachycardia—Prednisolone—multiple sclerosis	0.0017	0.00176	CcSEcCtD
Trospium—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.0017	0.00176	CcSEcCtD
Trospium—Urticaria—Mitoxantrone—multiple sclerosis	0.00169	0.00175	CcSEcCtD
Trospium—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00169	0.00174	CcSEcCtD
Trospium—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00168	0.00174	CcSEcCtD
Trospium—Vomiting—Azathioprine—multiple sclerosis	0.00167	0.00173	CcSEcCtD
Trospium—Eye disorder—Prednisone—multiple sclerosis	0.00167	0.00172	CcSEcCtD
Trospium—Infestation NOS—Methotrexate—multiple sclerosis	0.00166	0.00172	CcSEcCtD
Trospium—Infestation—Methotrexate—multiple sclerosis	0.00166	0.00172	CcSEcCtD
Trospium—Rash—Azathioprine—multiple sclerosis	0.00166	0.00172	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00166	0.00172	CcSEcCtD
Trospium—Dermatitis—Azathioprine—multiple sclerosis	0.00166	0.00171	CcSEcCtD
Trospium—Flushing—Prednisone—multiple sclerosis	0.00166	0.00171	CcSEcCtD
Trospium—Headache—Azathioprine—multiple sclerosis	0.00165	0.0017	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00165	0.0017	CcSEcCtD
Trospium—Dry mouth—Triamcinolone—multiple sclerosis	0.00164	0.00169	CcSEcCtD
Trospium—Angioedema—Betamethasone—multiple sclerosis	0.00163	0.00169	CcSEcCtD
Trospium—Angioedema—Dexamethasone—multiple sclerosis	0.00163	0.00169	CcSEcCtD
Trospium—Stomatitis—Methotrexate—multiple sclerosis	0.00162	0.00167	CcSEcCtD
Trospium—Angiopathy—Prednisone—multiple sclerosis	0.00162	0.00167	CcSEcCtD
Trospium—Confusional state—Methylprednisolone—multiple sclerosis	0.00162	0.00167	CcSEcCtD
Trospium—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00161	0.00166	CcSEcCtD
Trospium—Oedema—Triamcinolone—multiple sclerosis	0.00161	0.00166	CcSEcCtD
Trospium—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.0016	0.00166	CcSEcCtD
Trospium—Syncope—Dexamethasone—multiple sclerosis	0.0016	0.00165	CcSEcCtD
Trospium—Syncope—Betamethasone—multiple sclerosis	0.0016	0.00165	CcSEcCtD
Trospium—Infection—Triamcinolone—multiple sclerosis	0.0016	0.00165	CcSEcCtD
Trospium—Infection—Methylprednisolone—multiple sclerosis	0.00159	0.00164	CcSEcCtD
Trospium—Haematuria—Methotrexate—multiple sclerosis	0.00159	0.00164	CcSEcCtD
Trospium—Shock—Triamcinolone—multiple sclerosis	0.00158	0.00163	CcSEcCtD
Trospium—Shock—Methylprednisolone—multiple sclerosis	0.00158	0.00163	CcSEcCtD
Trospium—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00157	0.00162	CcSEcCtD
Trospium—Loss of consciousness—Betamethasone—multiple sclerosis	0.00157	0.00162	CcSEcCtD
Trospium—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00157	0.00162	CcSEcCtD
Trospium—Tachycardia—Triamcinolone—multiple sclerosis	0.00157	0.00162	CcSEcCtD
Trospium—Nausea—Azathioprine—multiple sclerosis	0.00156	0.00162	CcSEcCtD
Trospium—Tachycardia—Methylprednisolone—multiple sclerosis	0.00156	0.00162	CcSEcCtD
Trospium—Skin disorder—Methylprednisolone—multiple sclerosis	0.00156	0.00161	CcSEcCtD
Trospium—Malnutrition—Prednisone—multiple sclerosis	0.00155	0.00161	CcSEcCtD
Trospium—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00155	0.0016	CcSEcCtD
Trospium—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00155	0.0016	CcSEcCtD
Trospium—Asthenia—Mitoxantrone—multiple sclerosis	0.00153	0.00158	CcSEcCtD
Trospium—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00147	0.00152	CcSEcCtD
Trospium—Vision blurred—Prednisone—multiple sclerosis	0.00147	0.00151	CcSEcCtD
Trospium—Urethral disorder—Methotrexate—multiple sclerosis	0.00146	0.00151	CcSEcCtD
Trospium—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00146	0.00151	CcSEcCtD
Trospium—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00146	0.00151	CcSEcCtD
Trospium—Oedema—Betamethasone—multiple sclerosis	0.00146	0.00151	CcSEcCtD
Trospium—Oedema—Dexamethasone—multiple sclerosis	0.00146	0.00151	CcSEcCtD
Trospium—Infection—Betamethasone—multiple sclerosis	0.00145	0.0015	CcSEcCtD
Trospium—Infection—Dexamethasone—multiple sclerosis	0.00145	0.0015	CcSEcCtD
Trospium—Feeling abnormal—Prednisolone—multiple sclerosis	0.00144	0.00149	CcSEcCtD
Trospium—Visual impairment—Methotrexate—multiple sclerosis	0.00144	0.00149	CcSEcCtD
Trospium—Shock—Dexamethasone—multiple sclerosis	0.00143	0.00148	CcSEcCtD
Trospium—Shock—Betamethasone—multiple sclerosis	0.00143	0.00148	CcSEcCtD
Trospium—Nervous system disorder—Betamethasone—multiple sclerosis	0.00143	0.00148	CcSEcCtD
Trospium—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00143	0.00148	CcSEcCtD
Trospium—Tachycardia—Dexamethasone—multiple sclerosis	0.00142	0.00147	CcSEcCtD
Trospium—Tachycardia—Betamethasone—multiple sclerosis	0.00142	0.00147	CcSEcCtD
Trospium—Angioedema—Prednisone—multiple sclerosis	0.00142	0.00147	CcSEcCtD
Trospium—Dyspepsia—Triamcinolone—multiple sclerosis	0.00141	0.00146	CcSEcCtD
Trospium—Erythema multiforme—Methotrexate—multiple sclerosis	0.00141	0.00146	CcSEcCtD
Trospium—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00141	0.00146	CcSEcCtD
Trospium—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00141	0.00146	CcSEcCtD
Trospium—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00141	0.00146	CcSEcCtD
Trospium—Eye disorder—Methotrexate—multiple sclerosis	0.00139	0.00144	CcSEcCtD
Trospium—Syncope—Prednisone—multiple sclerosis	0.00139	0.00144	CcSEcCtD
Trospium—Urticaria—Prednisolone—multiple sclerosis	0.00139	0.00143	CcSEcCtD
Trospium—Cardiac disorder—Methotrexate—multiple sclerosis	0.00139	0.00143	CcSEcCtD
Trospium—Fatigue—Triamcinolone—multiple sclerosis	0.00138	0.00143	CcSEcCtD
Trospium—Fatigue—Methylprednisolone—multiple sclerosis	0.00138	0.00143	CcSEcCtD
Trospium—Loss of consciousness—Prednisone—multiple sclerosis	0.00137	0.00141	CcSEcCtD
Trospium—Angiopathy—Methotrexate—multiple sclerosis	0.00135	0.0014	CcSEcCtD
Trospium—Vomiting—Mitoxantrone—multiple sclerosis	0.00135	0.0014	CcSEcCtD
Trospium—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00135	0.00139	CcSEcCtD
Trospium—Rash—Mitoxantrone—multiple sclerosis	0.00134	0.00139	CcSEcCtD
Trospium—Dermatitis—Mitoxantrone—multiple sclerosis	0.00134	0.00139	CcSEcCtD
Trospium—Headache—Mitoxantrone—multiple sclerosis	0.00133	0.00138	CcSEcCtD
Trospium—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00132	0.00137	CcSEcCtD
Trospium—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00132	0.00136	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00131	0.00136	CcSEcCtD
Trospium—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00131	0.00135	CcSEcCtD
Trospium—Malnutrition—Methotrexate—multiple sclerosis	0.0013	0.00134	CcSEcCtD
Trospium—Dyspepsia—Dexamethasone—multiple sclerosis	0.00128	0.00133	CcSEcCtD
Trospium—Dyspepsia—Betamethasone—multiple sclerosis	0.00128	0.00133	CcSEcCtD
Trospium—Urticaria—Triamcinolone—multiple sclerosis	0.00128	0.00132	CcSEcCtD
Trospium—Urticaria—Methylprednisolone—multiple sclerosis	0.00127	0.00132	CcSEcCtD
Trospium—Dysgeusia—Methotrexate—multiple sclerosis	0.00127	0.00131	CcSEcCtD
Trospium—Anaphylactic shock—Prednisone—multiple sclerosis	0.00127	0.00131	CcSEcCtD
Trospium—Oedema—Prednisone—multiple sclerosis	0.00127	0.00131	CcSEcCtD
Trospium—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00127	0.00131	CcSEcCtD
Trospium—Decreased appetite—Betamethasone—multiple sclerosis	0.00127	0.00131	CcSEcCtD
Trospium—Decreased appetite—Dexamethasone—multiple sclerosis	0.00127	0.00131	CcSEcCtD
Trospium—Nausea—Mitoxantrone—multiple sclerosis	0.00126	0.00131	CcSEcCtD
Trospium—Infection—Prednisone—multiple sclerosis	0.00126	0.0013	CcSEcCtD
Trospium—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00126	0.0013	CcSEcCtD
Trospium—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00126	0.0013	CcSEcCtD
Trospium—Back pain—Methotrexate—multiple sclerosis	0.00126	0.0013	CcSEcCtD
Trospium—Fatigue—Dexamethasone—multiple sclerosis	0.00126	0.0013	CcSEcCtD
Trospium—Fatigue—Betamethasone—multiple sclerosis	0.00126	0.0013	CcSEcCtD
Trospium—Shock—Prednisone—multiple sclerosis	0.00125	0.00129	CcSEcCtD
Trospium—Nervous system disorder—Prednisone—multiple sclerosis	0.00124	0.00129	CcSEcCtD
Trospium—Tachycardia—Prednisone—multiple sclerosis	0.00124	0.00128	CcSEcCtD
Trospium—Skin disorder—Prednisone—multiple sclerosis	0.00123	0.00127	CcSEcCtD
Trospium—Hyperhidrosis—Prednisone—multiple sclerosis	0.00123	0.00127	CcSEcCtD
Trospium—Vision blurred—Methotrexate—multiple sclerosis	0.00122	0.00127	CcSEcCtD
Trospium—Feeling abnormal—Dexamethasone—multiple sclerosis	0.0012	0.00124	CcSEcCtD
Trospium—Feeling abnormal—Betamethasone—multiple sclerosis	0.0012	0.00124	CcSEcCtD
Trospium—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00119	0.00123	CcSEcCtD
Trospium—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00119	0.00123	CcSEcCtD
Trospium—Urticaria—Dexamethasone—multiple sclerosis	0.00116	0.0012	CcSEcCtD
Trospium—Urticaria—Betamethasone—multiple sclerosis	0.00116	0.0012	CcSEcCtD
Trospium—Dizziness—Prednisolone—multiple sclerosis	0.00115	0.00119	CcSEcCtD
Trospium—Asthenia—Triamcinolone—multiple sclerosis	0.00115	0.00119	CcSEcCtD
Trospium—Abdominal pain—Dexamethasone—multiple sclerosis	0.00115	0.00119	CcSEcCtD
Trospium—Abdominal pain—Betamethasone—multiple sclerosis	0.00115	0.00119	CcSEcCtD
Trospium—Asthenia—Methylprednisolone—multiple sclerosis	0.00115	0.00119	CcSEcCtD
Trospium—Pruritus—Triamcinolone—multiple sclerosis	0.00114	0.00117	CcSEcCtD
Trospium—Pruritus—Methylprednisolone—multiple sclerosis	0.00113	0.00117	CcSEcCtD
Trospium—Dyspepsia—Prednisone—multiple sclerosis	0.00112	0.00115	CcSEcCtD
Trospium—Chest pain—Methotrexate—multiple sclerosis	0.00111	0.00114	CcSEcCtD
Trospium—Decreased appetite—Prednisone—multiple sclerosis	0.0011	0.00114	CcSEcCtD
Trospium—Rash—Prednisolone—multiple sclerosis	0.0011	0.00114	CcSEcCtD
Trospium—Dermatitis—Prednisolone—multiple sclerosis	0.0011	0.00114	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.0011	0.00114	CcSEcCtD
Trospium—Fatigue—Prednisone—multiple sclerosis	0.00109	0.00113	CcSEcCtD
Trospium—Headache—Prednisolone—multiple sclerosis	0.00109	0.00113	CcSEcCtD
Trospium—Constipation—Prednisone—multiple sclerosis	0.00108	0.00112	CcSEcCtD
Trospium—Confusional state—Methotrexate—multiple sclerosis	0.00107	0.00111	CcSEcCtD
Trospium—Dizziness—Triamcinolone—multiple sclerosis	0.00106	0.0011	CcSEcCtD
Trospium—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00106	0.0011	CcSEcCtD
Trospium—Dizziness—Methylprednisolone—multiple sclerosis	0.00106	0.00109	CcSEcCtD
Trospium—Infection—Methotrexate—multiple sclerosis	0.00105	0.00109	CcSEcCtD
Trospium—Feeling abnormal—Prednisone—multiple sclerosis	0.00105	0.00108	CcSEcCtD
Trospium—Asthenia—Dexamethasone—multiple sclerosis	0.00105	0.00108	CcSEcCtD
Trospium—Asthenia—Betamethasone—multiple sclerosis	0.00105	0.00108	CcSEcCtD
Trospium—Nervous system disorder—Methotrexate—multiple sclerosis	0.00104	0.00107	CcSEcCtD
Trospium—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00104	0.00107	CcSEcCtD
Trospium—Nausea—Prednisolone—multiple sclerosis	0.00104	0.00107	CcSEcCtD
Trospium—Pruritus—Dexamethasone—multiple sclerosis	0.00103	0.00107	CcSEcCtD
Trospium—Pruritus—Betamethasone—multiple sclerosis	0.00103	0.00107	CcSEcCtD
Trospium—Skin disorder—Methotrexate—multiple sclerosis	0.00103	0.00106	CcSEcCtD
Trospium—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00103	0.00106	CcSEcCtD
Trospium—Vomiting—Triamcinolone—multiple sclerosis	0.00102	0.00106	CcSEcCtD
Trospium—Vomiting—Methylprednisolone—multiple sclerosis	0.00102	0.00105	CcSEcCtD
Trospium—Rash—Triamcinolone—multiple sclerosis	0.00101	0.00105	CcSEcCtD
Trospium—Dermatitis—Triamcinolone—multiple sclerosis	0.00101	0.00105	CcSEcCtD
Trospium—Rash—Methylprednisolone—multiple sclerosis	0.00101	0.00104	CcSEcCtD
Trospium—Dermatitis—Methylprednisolone—multiple sclerosis	0.00101	0.00104	CcSEcCtD
Trospium—Urticaria—Prednisone—multiple sclerosis	0.00101	0.00104	CcSEcCtD
Trospium—Headache—Triamcinolone—multiple sclerosis	0.00101	0.00104	CcSEcCtD
Trospium—Headache—Methylprednisolone—multiple sclerosis	0.001	0.00104	CcSEcCtD
Trospium—Abdominal pain—Prednisone—multiple sclerosis	0.001	0.00104	CcSEcCtD
Trospium—Dizziness—Betamethasone—multiple sclerosis	0.000963	0.000996	CcSEcCtD
Trospium—Dizziness—Dexamethasone—multiple sclerosis	0.000963	0.000996	CcSEcCtD
Trospium—Nausea—Triamcinolone—multiple sclerosis	0.000954	0.000986	CcSEcCtD
Trospium—Nausea—Methylprednisolone—multiple sclerosis	0.000952	0.000984	CcSEcCtD
Trospium—Somnolence—Methotrexate—multiple sclerosis	0.000943	0.000974	CcSEcCtD
Trospium—Dyspepsia—Methotrexate—multiple sclerosis	0.000933	0.000965	CcSEcCtD
Trospium—Vomiting—Dexamethasone—multiple sclerosis	0.000926	0.000957	CcSEcCtD
Trospium—Vomiting—Betamethasone—multiple sclerosis	0.000926	0.000957	CcSEcCtD
Trospium—Decreased appetite—Methotrexate—multiple sclerosis	0.000922	0.000953	CcSEcCtD
Trospium—Rash—Dexamethasone—multiple sclerosis	0.000919	0.000949	CcSEcCtD
Trospium—Rash—Betamethasone—multiple sclerosis	0.000919	0.000949	CcSEcCtD
Trospium—Dermatitis—Betamethasone—multiple sclerosis	0.000918	0.000949	CcSEcCtD
Trospium—Dermatitis—Dexamethasone—multiple sclerosis	0.000918	0.000949	CcSEcCtD
Trospium—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000915	0.000946	CcSEcCtD
Trospium—Fatigue—Methotrexate—multiple sclerosis	0.000914	0.000945	CcSEcCtD
Trospium—Headache—Betamethasone—multiple sclerosis	0.000913	0.000943	CcSEcCtD
Trospium—Headache—Dexamethasone—multiple sclerosis	0.000913	0.000943	CcSEcCtD
Trospium—Asthenia—Prednisone—multiple sclerosis	0.00091	0.000941	CcSEcCtD
Trospium—Pruritus—Prednisone—multiple sclerosis	0.000898	0.000928	CcSEcCtD
Trospium—Feeling abnormal—Methotrexate—multiple sclerosis	0.000874	0.000903	CcSEcCtD
Trospium—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000867	0.000896	CcSEcCtD
Trospium—Nausea—Dexamethasone—multiple sclerosis	0.000865	0.000894	CcSEcCtD
Trospium—Nausea—Betamethasone—multiple sclerosis	0.000865	0.000894	CcSEcCtD
Trospium—Urticaria—Methotrexate—multiple sclerosis	0.000842	0.000871	CcSEcCtD
Trospium—Dizziness—Prednisone—multiple sclerosis	0.000839	0.000867	CcSEcCtD
Trospium—Abdominal pain—Methotrexate—multiple sclerosis	0.000838	0.000866	CcSEcCtD
Trospium—Vomiting—Prednisone—multiple sclerosis	0.000807	0.000834	CcSEcCtD
Trospium—Rash—Prednisone—multiple sclerosis	0.0008	0.000827	CcSEcCtD
Trospium—Dermatitis—Prednisone—multiple sclerosis	0.000799	0.000826	CcSEcCtD
Trospium—Headache—Prednisone—multiple sclerosis	0.000795	0.000821	CcSEcCtD
Trospium—Asthenia—Methotrexate—multiple sclerosis	0.000761	0.000786	CcSEcCtD
Trospium—Nausea—Prednisone—multiple sclerosis	0.000754	0.000779	CcSEcCtD
Trospium—Pruritus—Methotrexate—multiple sclerosis	0.00075	0.000775	CcSEcCtD
Trospium—Dizziness—Methotrexate—multiple sclerosis	0.000701	0.000725	CcSEcCtD
Trospium—Vomiting—Methotrexate—multiple sclerosis	0.000674	0.000697	CcSEcCtD
Trospium—Rash—Methotrexate—multiple sclerosis	0.000669	0.000691	CcSEcCtD
Trospium—Dermatitis—Methotrexate—multiple sclerosis	0.000668	0.00069	CcSEcCtD
Trospium—Headache—Methotrexate—multiple sclerosis	0.000664	0.000687	CcSEcCtD
Trospium—Nausea—Methotrexate—multiple sclerosis	0.00063	0.000651	CcSEcCtD
Trospium—CHRM3—GPCR ligand binding—CNR1—multiple sclerosis	3.07e-05	0.00231	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—RGS1—multiple sclerosis	3.07e-05	0.00231	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—RGS1—multiple sclerosis	3.06e-05	0.0023	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—CNR1—multiple sclerosis	3.04e-05	0.00229	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—RGS1—multiple sclerosis	3.03e-05	0.00228	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—CXCL13—multiple sclerosis	2.93e-05	0.0022	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—CCR1—multiple sclerosis	2.93e-05	0.0022	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—CXCL13—multiple sclerosis	2.92e-05	0.00219	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—CCR1—multiple sclerosis	2.92e-05	0.00219	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—GPR65—multiple sclerosis	2.91e-05	0.00219	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—GPR65—multiple sclerosis	2.9e-05	0.00218	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—CCR1—multiple sclerosis	2.89e-05	0.00217	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—CXCL13—multiple sclerosis	2.89e-05	0.00217	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—GPR65—multiple sclerosis	2.87e-05	0.00216	CbGpPWpGaD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	2.83e-05	0.00212	CbGpPWpGaD
Trospium—CHRM2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	2.82e-05	0.00212	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	2.82e-05	0.00212	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—LINGO1—multiple sclerosis	2.81e-05	0.00211	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—LINGO1—multiple sclerosis	2.8e-05	0.00211	CbGpPWpGaD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	2.79e-05	0.0021	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—LINGO1—multiple sclerosis	2.77e-05	0.00209	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—CXCL10—multiple sclerosis	2.77e-05	0.00209	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—CXCL10—multiple sclerosis	2.77e-05	0.00208	CbGpPWpGaD
Trospium—CHRM2—G alpha (i) signalling events—POMC—multiple sclerosis	2.74e-05	0.00206	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—CXCL10—multiple sclerosis	2.74e-05	0.00206	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CYP24A1—multiple sclerosis	2.7e-05	0.00203	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CYP27B1—multiple sclerosis	2.7e-05	0.00203	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—CCR1—multiple sclerosis	2.66e-05	0.002	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—CXCL13—multiple sclerosis	2.66e-05	0.002	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—CXCL13—multiple sclerosis	2.65e-05	0.00199	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—CCR1—multiple sclerosis	2.65e-05	0.00199	CbGpPWpGaD
Trospium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	2.65e-05	0.00199	CbGpPWpGaD
Trospium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	2.64e-05	0.00199	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—CCR1—multiple sclerosis	2.62e-05	0.00197	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—CXCL13—multiple sclerosis	2.62e-05	0.00197	CbGpPWpGaD
Trospium—CHRM3—Metabolism—GPC5—multiple sclerosis	2.47e-05	0.00186	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—TAGAP—multiple sclerosis	2.44e-05	0.00183	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—TAGAP—multiple sclerosis	2.43e-05	0.00183	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TAGAP—multiple sclerosis	2.41e-05	0.00181	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—CCL5—multiple sclerosis	2.39e-05	0.0018	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—CCL5—multiple sclerosis	2.38e-05	0.00179	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—CCL5—multiple sclerosis	2.36e-05	0.00177	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—SRM—multiple sclerosis	2.29e-05	0.00172	CbGpPWpGaD
Trospium—CHRM1—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	2.26e-05	0.0017	CbGpPWpGaD
Trospium—CHRM3—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	2.25e-05	0.00169	CbGpPWpGaD
Trospium—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	2.23e-05	0.00168	CbGpPWpGaD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.21e-05	0.00166	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.2e-05	0.00165	CbGpPWpGaD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.18e-05	0.00164	CbGpPWpGaD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.16e-05	0.00162	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.15e-05	0.00162	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—CCR5—multiple sclerosis	2.15e-05	0.00162	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—CCR5—multiple sclerosis	2.14e-05	0.00161	CbGpPWpGaD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.13e-05	0.0016	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—S1PR1—multiple sclerosis	2.13e-05	0.0016	CbGpPWpGaD
Trospium—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.12e-05	0.0016	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	2.12e-05	0.0016	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—S1PR1—multiple sclerosis	2.12e-05	0.0016	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	2.1e-05	0.00158	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—GPC5—multiple sclerosis	2.07e-05	0.00156	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—GPC5—multiple sclerosis	2.07e-05	0.00155	CbGpPWpGaD
Trospium—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.05e-05	0.00154	CbGpPWpGaD
Trospium—CHRM3—Metabolism—RRM1—multiple sclerosis	2.05e-05	0.00154	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	2.05e-05	0.00154	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	2.01e-05	0.00151	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—PTGER4—multiple sclerosis	2e-05	0.0015	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	1.98e-05	0.00149	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	1.94e-05	0.00146	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—CXCR3—multiple sclerosis	1.93e-05	0.00145	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	1.91e-05	0.00144	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—CCL3—multiple sclerosis	1.89e-05	0.00142	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—CCL3—multiple sclerosis	1.89e-05	0.00142	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—CCR2—multiple sclerosis	1.89e-05	0.00142	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—CCR2—multiple sclerosis	1.88e-05	0.00141	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	1.87e-05	0.00141	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	1.86e-05	0.0014	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—PTGER4—multiple sclerosis	1.82e-05	0.00137	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—PTGER4—multiple sclerosis	1.82e-05	0.00137	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—RGS1—multiple sclerosis	1.81e-05	0.00136	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—RGS1—multiple sclerosis	1.81e-05	0.00136	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	1.8e-05	0.00135	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	1.79e-05	0.00134	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—CXCR3—multiple sclerosis	1.76e-05	0.00132	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—CXCR3—multiple sclerosis	1.76e-05	0.00132	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	1.74e-05	0.00131	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	1.74e-05	0.00131	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—CNR1—multiple sclerosis	1.74e-05	0.0013	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	1.72e-05	0.00129	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	1.72e-05	0.00129	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	1.71e-05	0.00129	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—GPR65—multiple sclerosis	1.71e-05	0.00129	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—CCR2—multiple sclerosis	1.71e-05	0.00128	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	1.7e-05	0.00127	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	1.69e-05	0.00127	CbGpPWpGaD
Trospium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	1.69e-05	0.00127	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	1.68e-05	0.00126	CbGpPWpGaD
Trospium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	1.68e-05	0.00126	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—POMC—multiple sclerosis	1.68e-05	0.00126	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	1.66e-05	0.00125	CbGpPWpGaD
Trospium—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.65e-05	0.00124	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	1.65e-05	0.00124	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	1.64e-05	0.00123	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	1.62e-05	0.00122	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.62e-05	0.00121	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.62e-05	0.00121	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	1.58e-05	0.00119	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	1.58e-05	0.00118	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	1.57e-05	0.00118	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	1.57e-05	0.00118	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	1.57e-05	0.00118	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	1.57e-05	0.00118	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	1.57e-05	0.00118	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	1.56e-05	0.00117	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	1.56e-05	0.00117	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	1.55e-05	0.00117	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	1.55e-05	0.00117	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	1.55e-05	0.00116	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.48e-05	0.00111	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	1.42e-05	0.00107	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	1.42e-05	0.00107	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	1.41e-05	0.00106	CbGpPWpGaD
Trospium—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	1.37e-05	0.00103	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	1.35e-05	0.00101	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	1.35e-05	0.00101	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	1.33e-05	0.001	CbGpPWpGaD
Trospium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.3e-05	0.000974	CbGpPWpGaD
Trospium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.29e-05	0.000971	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	1.23e-05	0.000921	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.22e-05	0.00092	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	1.22e-05	0.000918	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	1.22e-05	0.000914	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	1.21e-05	0.000911	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	1.21e-05	0.000909	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	1.2e-05	0.000902	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.2e-05	0.000901	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	1.19e-05	0.000898	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	1.18e-05	0.000889	CbGpPWpGaD
Trospium—CHRM3—Metabolism—BCHE—multiple sclerosis	1.18e-05	0.000884	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	1.12e-05	0.000841	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	1.12e-05	0.000839	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	1.1e-05	0.000831	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	1.1e-05	0.00083	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	1.1e-05	0.000827	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	1.09e-05	0.000819	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	1.09e-05	0.000818	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	1.08e-05	0.000815	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	1.08e-05	0.00081	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	1.07e-05	0.000807	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	1.07e-05	0.000807	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	1.06e-05	0.000799	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PGR—multiple sclerosis	1.06e-05	0.000798	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PGR—multiple sclerosis	1.06e-05	0.000795	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PGR—multiple sclerosis	1.05e-05	0.000787	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	1.04e-05	0.000782	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	1.04e-05	0.00078	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CD28—multiple sclerosis	1.03e-05	0.000775	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CD28—multiple sclerosis	1.03e-05	0.000772	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	1.03e-05	0.000772	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CD28—multiple sclerosis	1.02e-05	0.000765	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	1.01e-05	0.000761	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	1.01e-05	0.000758	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	9.99e-06	0.000751	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	9.5e-06	0.000714	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	9.47e-06	0.000712	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	9.38e-06	0.000705	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	9.34e-06	0.000702	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	9.31e-06	0.0007	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	9.22e-06	0.000693	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	8.63e-06	0.000649	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	8.6e-06	0.000647	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	8.52e-06	0.00064	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	8.44e-06	0.000635	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	8.42e-06	0.000633	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	8.41e-06	0.000632	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	8.38e-06	0.00063	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	8.33e-06	0.000627	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	8.3e-06	0.000624	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	7.67e-06	0.000576	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	7.64e-06	0.000574	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	7.57e-06	0.000569	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CD86—multiple sclerosis	7.35e-06	0.000553	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CD86—multiple sclerosis	7.33e-06	0.000551	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CD86—multiple sclerosis	7.26e-06	0.000546	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	7.24e-06	0.000544	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	7.22e-06	0.000542	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	7.15e-06	0.000537	CbGpPWpGaD
Trospium—CHRM3—Metabolism—APOE—multiple sclerosis	7.07e-06	0.000532	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—BCHE—multiple sclerosis	7.03e-06	0.000529	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	7.02e-06	0.000528	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	7e-06	0.000526	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	6.93e-06	0.000521	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	6.7e-06	0.000504	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	6.68e-06	0.000502	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	6.62e-06	0.000498	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	6.52e-06	0.00049	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	6.5e-06	0.000489	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	6.44e-06	0.000484	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	6.43e-06	0.000483	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	6.41e-06	0.000482	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	6.38e-06	0.00048	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	6.36e-06	0.000478	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	6.35e-06	0.000477	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	6.3e-06	0.000473	CbGpPWpGaD
Trospium—CHRM3—Metabolism—POMC—multiple sclerosis	6.08e-06	0.000457	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—APOE—multiple sclerosis	5.93e-06	0.000446	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—APOE—multiple sclerosis	5.91e-06	0.000445	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—APOE—multiple sclerosis	5.86e-06	0.00044	CbGpPWpGaD
Trospium—CHRM3—Metabolism—ALB—multiple sclerosis	5.54e-06	0.000416	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CD80—multiple sclerosis	5.36e-06	0.000403	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CD80—multiple sclerosis	5.35e-06	0.000402	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CD80—multiple sclerosis	5.3e-06	0.000398	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—POMC—multiple sclerosis	5.1e-06	0.000383	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—POMC—multiple sclerosis	5.08e-06	0.000382	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—POMC—multiple sclerosis	5.03e-06	0.000378	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	4.99e-06	0.000375	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	4.97e-06	0.000374	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	4.92e-06	0.00037	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	4.88e-06	0.000367	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	4.86e-06	0.000366	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	4.82e-06	0.000362	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	4.53e-06	0.00034	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	4.51e-06	0.000339	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	4.47e-06	0.000336	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—APOE—multiple sclerosis	4.23e-06	0.000318	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—IL2—multiple sclerosis	3.77e-06	0.000283	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—IL2—multiple sclerosis	3.76e-06	0.000282	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	3.75e-06	0.000282	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	3.74e-06	0.000281	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—IL2—multiple sclerosis	3.72e-06	0.00028	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	3.7e-06	0.000278	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—POMC—multiple sclerosis	3.63e-06	0.000273	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	3.57e-06	0.000268	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	3.56e-06	0.000267	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	3.52e-06	0.000265	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ALB—multiple sclerosis	3.31e-06	0.000249	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	3.17e-06	0.000238	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	3.16e-06	0.000238	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	3.13e-06	0.000235	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MYC—multiple sclerosis	2.95e-06	0.000222	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	2.94e-06	0.000221	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MYC—multiple sclerosis	2.94e-06	0.000221	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	2.93e-06	0.00022	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MYC—multiple sclerosis	2.91e-06	0.000219	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	2.9e-06	0.000218	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	2.88e-06	0.000217	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	2.87e-06	0.000216	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	2.85e-06	0.000214	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—IL6—multiple sclerosis	2.21e-06	0.000167	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—IL6—multiple sclerosis	2.21e-06	0.000166	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—IL6—multiple sclerosis	2.19e-06	0.000164	CbGpPWpGaD
